Physician profile
Patrick J Corpora
NPI 1306367131
$2,306.31
in general payments reported to CMS, 2019-2025
16 companies · $468 in 2025
The $468 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $113 · 2021: $117 · 2022: $537 · 2023: $220 · 2024: $585 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $415.43 | 2021-2025 | Cequa |
| Bausch & Lomb Americas INC. | $405.45 | 2023-2025 | Infuse, Miebo, Vyzulta |
| Alcon Vision LLC | $344.29 | 2019-2025 | Total30, Tryptyr, Precision7 |
| Johnson & Johnson Vision Care, INC. | $268.24 | 2019-2025 | Acuvue |
| Coopervision INC. | $213.36 | 2019-2025 | Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $174.71 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $136.30 | 2022-2024 | Tyrvaya |
| Biotissue Holdings INC. | $132.10 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $58.79 | 2020-2022 | |
| Dompe US, INC. | $39.52 | 2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.03 | 2019-2020 | |
| Rxsight INC | $21.56 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Shire North American Group INC | $18.88 | 2019 | |
| Lkc Technologies, INC. | $15.25 | 2025 | |
| Abbvie INC. | $14.14 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Corpora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.